The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2012 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2012 AAPM Annual Meeting « Back

    170

    Long-Term Improvements Show Mild® Percutaneous Procedure Durability

    Timothy R. Deer, MD, doctdeer@aol.com, The Center for Pain Relief, Charleston, West Virginia

    View Poster

    Introduction: When nonsurgical approaches become inadequate in alleviating symptoms of neurogenic claudication in lumbar spinal stenosis (LSS) patients, surgery is usually considered. Surgical options range from minimally invasive decompression to open laminectomy with fusion. As a minimally invasive alternative to open surgery, the mild decompression procedure is performed through a tiny portal under fluoroscopic guidance. Mild minimizes injury to surrounding soft tissue, bone, and ligament. Further, general anesthesia is not required and patients are generally discharged on the same day as the procedure. Mild offers a new option for LSS patients suffering from neurogenic claudication, who are unwilling or not medically indicated to undergo open surgery. Objective: To assess patient outcomes 2 years after lumbar decompression with mild. Materials and Methods: Patients diagnosed with radiographically confirmed LSS exhibiting symptoms of neurogenic claudication were treated in this IRB-approved, prospective, multicenter study. Posttreatment outcome measurements include Visual Analog Score (VAS), Oswestry Disability Index (ODI), Zurich Claudication Questionnaire (ZCQ), and SF-12v2® Health Survey. Poststudy follow-up was obtained through Year 2. This study was registered on the U.S. Clinical Trial Registry. Results: Through 2-year follow-up, no serious mild safety issues were reported. Patients achieved and maintained significant pain reduction as measured by VAS, ZCQ, and SF-12v2. Significant physical function and mobility improvement were confirmed using ODI, ZCQ, and SF-12v2. Conclusions: Based on 2-year posttreatment results, mild provides durable improvement in pain, mobility, and physical quality of life for LSS patients. The mild procedure is a safe option in the LSS treatment algorithm.

    Funding: None

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In